Comparative Double Blind Placebo Controlled Clinical Study on Tocilizumab Rapid Efficacy on Patients Relief in rheumatoid Arthritis With an Inadequate Response to DMARDs or Anti TNF
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2014
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms TORPEDO
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 08 Aug 2012 Actual patient number changed from 99 to 103 as reported by ClinicalTrials.gov.
- 08 Aug 2012 Actual end date (1 Apr 2012) added as reported by ClinicalTrials.gov.